OMRF researchers have broken new ground in understanding how the lymphatic system works.
develop
Staying alive: Can an experimental OMRF drug stop Mike Schuster’s brain cancer?
As Mike Schuster nears the three-year anniversary of his diagnosis with glioblastoma, he’s already doubled the life expectancy for patients with the deadly cancer.
OMRF receives $2.8 million grant to study rare disorder
The grant will provide Bob Axtell with $2.8 million to study NMO and investigate its similarities to other autoimmune diseases, particularly MS.
Experts propose improving clinical trials for lupus
The goal of the new white paper is to create a dramatic shift in how lupus clinical trials are conducted so effective treatments can stand a chance to succeed.
New colon cancer finding could lead to earlier diagnosis—and better outcomes
The most common method of screening for colon cancer is a colonoscopy. However, certain cancer-causing polyps can be easily missed during an examination.
Q BioMed Inc. finalizes license agreement with OMRF, RGCB
QBioMed has the global exclusive rights to develop and market a novel chemotherapeutic drug to treat liver cancer.
